Larvol Delta - PANACEA-MT601-Administered-To-Patients-With-Locally-Advanced-Unresectable-or-Metastatic-Pancreatic-Cancer

neldaleucel (MT-601) - Marker Therap

http://clinicaltrials.gov/ct2/show/NCT06549751

Aug 12, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next